MedTrace Logo

Validation of Hemorrhoidal Bleeding Score

NCT03060616 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2023-04-27

No results posted yet for this study

Summary

The principal manifestation of hemorrhoidal disease is bleeding; however the severity evaluation is today based on prolapsus (Goligher classification) and bleeding factor is not included.

Even if there was some rare score including bleeding in literature , none of them were validated.

The aim of the study is first validation of bleeding score .

Conditions

  • Hemorrhoid Bleeding

Sponsors & Collaborators

  • Fondation Hôpital Saint-Joseph

    lead OTHER

Principal Investigators

  • Hélène BEAUSSIER, Pharm-D · CRC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-01
Primary Completion
2018-03-15
Completion
2018-03-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03060616 on ClinicalTrials.gov